Skip to main content
M
Doctor-Reviewed Content Verified Hospital Data Updated Medical Information Patient-First Guidance Not for Emergencies — Call 911

Bartholin's Abscess Treatment: Word Catheter, Marsupialization, and Excision — Cost, Top Hospitals & Success Rates | MyMedicPlus

Updated: 2026-07-07
Ad — after-intro

Quick Facts

Anatomy
Paired glands at 4 and 8 o'clock of the vaginal introitus
Lifetime Incidence
~2% of women
Peak Age Group
20–30 years
First- Line Procedure
Word catheter insertion (4–6 week retention)
Word Catheter Success Rate
80–90% with adequate retention
Marsupialization Recurrence
5–10% long-term
M R S A Swab
Recommended at all presentations
Sexual Activity ( Word catheter)
Avoid penetrative intercourse for 4–6 weeks
Last Reviewed
2026-06-15
Reviewer
MyMedicPlus Medical Review Board

Overview

The Bartholin glands (greater vestibular glands) are a pair of mucus-secreting glands located bilaterally at the 4 and 8 o'clock positions of the vaginal introitus, beneath the labia majora. Each gland is approximately the size of a pea and normally imperceptible on examination. Its duct, approximately 2 cm in length, opens into the vestibule lateral to the hymen and continuously secretes a small amount of mucus to lubricate the vaginal introitus, particularly during sexual arousal.

Bartholin gland pathology arises in two principal forms:

  • Bartholin's cyst: Formed when the duct becomes obstructed (due to mucus thickening, scarring from prior infection, or congenital stenosis), causing mucus to accumulate and distend the gland. The cyst contains clear or cloudy mucoid fluid, is typically non-tender, may range from 1 cm to more than 6 cm in diameter, and is not infected. Small asymptomatic cysts may be managed expectantly.
  • Bartholin's abscess: An acute, painful, rapidly developing infection of the Bartholin gland or its duct, producing a hot, exquisitely tender, fluctuant swelling that can reach 3–4 cm in diameter within 24–48 hours. The overlying skin may be erythematous and oedematous. Women typically present with severe unilateral vulval pain, difficulty walking, sitting, or standing, and dyspareunia.

The incidence of Bartholin's cyst or abscess is approximately 2% over a woman's lifetime, with peak incidence between ages 20 and 30 years. The causative bacteriology is typically polymicrobial, including mixed vaginal flora anaerobes (Bacteroides species, Prevotella), aerobic Gram-negative rods (E. coli, Klebsiella), and Gram-positive organisms (Staphylococcus aureus, including MRSA, which has become an increasingly important pathogen). Neisseria gonorrhoeae and Chlamydia trachomatis can cause Bartholin's abscesses in sexually active women at risk of STIs and must be tested for with high vaginal/endocervical swabs at presentation.

Conditions Treated

Management decisions are guided by distinguishing between a Bartholin's cyst and an abscess, and by the woman's age and clinical presentation:

  • Symptomatic Bartholin's cyst: Cysts larger than 2–3 cm causing discomfort, dyspareunia, difficulty sitting, or recurrent infections warrant procedural treatment. Asymptomatic cysts below 2 cm, particularly in younger women, can be observed. Spontaneous rupture can occur but recurrence is common without fistula tract formation.
  • Bartholin's abscess: Acute infected abscess always requires procedural drainage; antibiotics alone without drainage are insufficient and inappropriate (cannot achieve adequate antibiotic penetration in a walled-off collection). Urgent same-day or next-day procedure is the standard of care.
  • Recurrent Bartholin's cyst or abscess: Recurrence affects approximately 5–15% of women after simple incision and drainage alone, and requires a definitive fistulisation procedure (Word catheter, marsupialization) or — for true recalcitrant cases — gland excision.
  • Bartholin's gland carcinoma: A critical diagnosis to exclude, particularly in women over 40 years old presenting with a vulval mass. Bartholin gland carcinoma is rare (1–2% of all vulval malignancies) but the cyst wall should be biopsied and sent for histopathological examination in any woman aged 40 or over undergoing excision or marsupialization. The distinction from benign cyst on imaging or clinical examination alone is unreliable.

Differential diagnoses to exclude:

  • Vulval abscess from skin or Skene's gland: presents differently — not at 4/8 o'clock positions, not associated with the gland itself.
  • Labial cyst (mucous retention cyst, inclusion cyst after episiotomy): non-tender, superficial, no deep glandular component.
  • Hidradenitis suppurativa: recurrent multifocal painful nodules and abscesses along hair-bearing skin; requires dedicated specialist management.
  • Lipoma, fibroma, or vulval varicosity: non-tender, slow-growing, no acute inflammatory features.

Eligibility and Pre-Procedure Assessment

All women with a symptomatic Bartholin's abscess require procedural treatment; the choice of specific procedure depends on clinical factors:

Word catheter insertion is appropriate for:

  • First or second presentation of Bartholin's abscess in women under 40.
  • Cysts suitable for outpatient same-day treatment under local anaesthetic.
  • Women who can comply with a 4–6 week catheter retention period and return for removal.

Marsupialization is preferred for:

  • Recurrent Bartholin's abscess or cyst (two or more episodes).
  • Large abscesses where Word catheter size may be insufficient to maintain drainage.
  • Women requesting a single more definitive procedure under regional or general anaesthesia in a theatre setting.

Gland excision is reserved for:

  • Multiple recurrences after failed marsupialization (three or more episodes).
  • Histopathological concern for malignancy (any woman over 40 where carcinoma cannot be excluded clinically).
  • Chronic recalcitrant Bartholin's gland disease unresponsive to all conservative measures.

Pre-procedure assessment should include:

  • High vaginal swab (HVS) and endocervical or vulval swab for MRSA screening, N. gonorrhoeae NAAT, and Chlamydia trachomatis NAAT — particularly if the woman has STI risk factors (new or multiple partners, inconsistent condom use).
  • Pregnancy test if reproductive-age woman (procedural anaesthesia choice and antibiotic selection are influenced by pregnancy).
  • Blood glucose in women with recurrent presentations (uncontrolled diabetes predisposes to recurrent vulval infections).
  • Allergy history (local anaesthetic, latex, antibiotics).

In pregnancy, conservative management (sitz baths, analgesics) is preferred in the first trimester if tolerable; Word catheter insertion under local anaesthetic is generally safe in the second and third trimesters.

Treatment Options

Treatment is selected based on lesion type, recurrence history, patient preference, and clinical setting:

1. Incision and Drainage (I&D) alone: A simple stab incision is made into the most fluctuant point of the abscess using a scalpel under local anaesthetic, pus is expressed by digital pressure, and the cavity irrigated with saline. Rapid pain relief is achieved. However, I&D alone has a recurrence rate of 15–20% within 12 months because the incision heals shut before a permanent fistulous tract forms. It is best reserved as a temporising measure when Word catheter cannot be placed (e.g., extreme pain, patient refusal, inadequate equipment).

2. Word Catheter Insertion (most common first-line procedure): A small stab incision (3–5 mm) is made through the vaginal mucosa into the abscess cavity. After pus is expressed and the cavity irrigated, a Word catheter (a small inflatable balloon-tipped catheter, 10 French) is inserted into the cavity and its balloon inflated with 2–3 mL of sterile water or saline. The catheter tail is tucked into the vaginal introitus for comfort. The patient returns — or removes it herself — at 4–6 weeks, by which time the inflated balloon has stimulated epithelialisation of a permanent fistulous tract (neo-ostium) from the gland to the vestibular surface, recreating the gland's natural drainage route. Success rate: 80–90% with adequate catheter retention time. Can be performed under local infiltration anaesthesia in 5–10 minutes in an outpatient or emergency department setting.

3. Marsupialization: Under regional or general anaesthesia in a theatre setting, an elliptical window of skin (1.5–2 cm) is excised over the cyst or abscess, the cyst/abscess wall is everted, and the edges sutured directly to the vulval skin with absorbable sutures (Vicryl 2-0 or 3-0). This creates a permanent wide-mouth opening from the gland to the vulval surface. Recurrence rate is 5–10% — significantly lower than I&D alone. Preferred for recurrent lesions and large abscesses not suited to Word catheter.

4. Silver Nitrate Ablation: After drainage via a stab incision, a silver nitrate stick is introduced into the empty cavity and rotated to chemically ablate the glandular epithelium, aiming to destroy the gland's secretory lining and cause permanent fibrosis. A simple, fast, and inexpensive procedure. Evidence is limited to small case series but shows comparable outcomes to marsupialization with lower morbidity.

5. Alcohol Sclerotherapy: After aspiration, 70% ethanol is injected into the cavity (equivalent volume to aspirated fluid) and left for 5 minutes before re-aspiration. Repeat in 1 week if needed. Used where Word catheter or marsupialization are unavailable or contraindicated.

6. Gland Excision (Bartholin glandectomy): Complete surgical removal of the Bartholin gland through a vestibular incision under general anaesthesia. Reserved as a last resort due to significant surgical morbidity: risk of damage to the vestibular bulb (causing haematoma), injury to the vaginal wall, wound breakdown, dyspareunia from scar contracture, and loss of gland secretory function. Blood loss can be substantial; the procedure requires experienced pelvic surgical skills.

Antibiotic therapy: Antibiotics are NOT routinely required for uncomplicated Bartholin's abscess drainage in immunocompetent women. Indications for antibiotics: cellulitis extending beyond the abscess cavity, features of systemic sepsis, MRSA identified on swab (target with doxycycline 100 mg BD, or trimethoprim-sulfamethoxazole per sensitivity), STI co-infection (treat N. gonorrhoeae and Chlamydia per local STI guidelines), or pregnancy (broader spectrum cover).

Benefits

Appropriate procedural treatment of Bartholin's abscess and cyst delivers rapid and definitive benefits:

  • Immediate pain relief: I&D, Word catheter insertion, and marsupialization all provide almost instantaneous relief from the severe vulval pain caused by abscess distension. Most women report the procedure itself — performed under effective local anaesthetic — is less painful than anticipated, and walk out of the clinic with dramatically reduced pain within minutes of drainage.
  • Prevention of abscess rupture and tracking: Untreated Bartholin's abscesses spontaneously rupture through the skin or vaginal wall, resulting in incomplete drainage, higher recurrence rates, and potential spread of infection to adjacent vulval tissues. Timely procedural drainage avoids these complications.
  • High success with fistulisation techniques: Word catheter insertion and marsupialization achieve 80–90% success in preventing recurrence by creating a permanent neo-ostium, as opposed to 60–85% recurrence with simple I&D over 2 years. Marsupialization specifically offers the highest definitive cure rate in recurrent disease (90–95% long-term success).
  • Preservation of gland function and sexual function: Word catheter insertion and marsupialization preserve the Bartholin gland's secretory capacity. This is clinically important as the Bartholin glands contribute to vestibular lubrication, and their loss (after excision) may cause vaginal dryness, particularly during sexual intercourse. Preserving gland function is an important advantage of non-excisional procedures.
  • Outpatient feasibility: Word catheter insertion under local anaesthetic is a same-day outpatient procedure achievable in emergency departments, GP surgical rooms, and gynaecology clinics without general anaesthesia — minimising risk, cost, and time to treatment.
  • Antibiotic stewardship: Definitive drainage eliminates the need for prolonged antibiotic courses, which would be ineffective in a walled-off abscess and contribute to antimicrobial resistance.

Risks and Complications

Each treatment modality carries specific risks that should be discussed as part of pre-procedure informed consent:

All drainage procedures:

  • Recurrence: The most common complication of any Bartholin's gland treatment. After I&D alone: 15–20% recurrence within 12 months. After Word catheter insertion: 5–10% if retained for full 4–6 weeks. After marsupialization: 5–10% long-term. After excision: less than 5% but procedural morbidity is highest.
  • Wound infection: Secondary cellulitis or wound infection develops in 3–5% of cases. Encourage sitz baths and maintain vulval hygiene post-procedure. Culture-guided antibiotics required if wound infection develops.

Word catheter-specific risks:

  • Premature catheter expulsion (catheter falls out before neo-ostium formation): occurs in approximately 10–15% of cases; more likely if balloon is insufficiently inflated or patient is very active. If catheter is expelled in the first 2 weeks, reinsertion is recommended.
  • Discomfort with catheter in situ: the catheter tail may cause local irritation or minor dyspareunia if the partner is unaware of its presence. Patients must abstain from penetrative sexual intercourse during the 4–6 week retention period.

Marsupialization-specific risks:

  • Haematoma: uncommon but recognised complication given the vascularity of the vestibular region. Requires evacuation if large.
  • Suture dehiscence or wound breakdown: particularly in the context of active infection at surgery. Usually heals by secondary intention without further intervention.
  • Dyspareunia from scar contracture: rare with careful surgical technique and adequate window size.

Gland excision-specific risks:

  • Significant intraoperative haemorrhage from vestibular bulb injury — the procedure should only be performed by experienced pelvic surgeons.
  • Haematoma (most common post-excisional complication): requires close wound monitoring and drainage if symptomatic.
  • Permanent dyspareunia and reduced vestibular lubrication due to loss of gland secretory function.
  • Rare: injury to the vaginal wall or perineal nerve branches.

Missed diagnosis risk: In women over 40, failing to biopsy and send the cyst wall for histopathology at excision or marsupialization risks missing Bartholin's gland carcinoma — a diagnosis that, if delayed, significantly worsens prognosis. This must be discussed as part of pre-procedure consent in older women.

Follow-Up and Recovery

Post-procedure care is straightforward but critically important for successful fistula tract formation and prevention of recurrence.

Word catheter (days 0 to 4–6 weeks):

  • Patients are discharged with the Word catheter in situ. The catheter tail should be tucked gently inside the vaginal introitus for comfort, particularly during walking and sleep.
  • Sitz baths: Warm sitz baths for 10–15 minutes, 2–3 times daily, reduce local inflammation, maintain hygiene, and are soothing. Continue until catheter is removed.
  • Activity: Walking and routine daily activities are encouraged. No restriction on gentle exercise. Avoid swimming (risk of infection through catheter insertion site) until catheter is removed.
  • Sexual activity: Penetrative vaginal intercourse must be avoided while the Word catheter is in situ (4–6 weeks). External stimulation is generally acceptable if comfortable.
  • Catheter removal: At 4–6 weeks, the balloon is deflated with a needle and syringe, and the catheter withdrawn. This takes seconds and is virtually painless. The neo-ostium (fistulous tract) formed in the gland surface is inspected.
  • Review for recurrence: Any recurrence of swelling, pain, or discharge after catheter removal should prompt review within 48 hours.

After marsupialization or excision:

  • Routine wound review at 1–2 weeks to check healing and assess for haematoma or infection.
  • Absorbable sutures require no removal — they dissolve over 3–4 weeks.
  • Resume normal sexual activity after wound healing is confirmed, typically at 4–6 weeks.
  • Recommend a 6-week post-operative gynaecology review; examine the wound and assess neo-ostium patency.

STI results and antibiotic course follow-up: Swab results typically return within 3–5 days. If N. gonorrhoeae is identified, test-of-cure is required at 2 weeks. Sexual contacts should be notified and tested per local STI contact tracing guidance. If MRSA is identified, decolonisation protocol (nasal mupirocin, chlorhexidine bodywash, antibiotic course) should be initiated with the support of a microbiologist or infectious disease specialist.

Women over 40: Histopathological results from biopsied cyst wall typically return within 7–10 days. Abnormal results necessitate urgent onward referral to gynaecological oncology for assessment of possible Bartholin gland carcinoma.

Cost Factors

Bartholin's abscess treatment costs depend primarily on the procedure chosen, the healthcare setting (emergency department, outpatient gynaecology clinic, or operating theatre), country, and public versus private healthcare access.

Incision and drainage (I&D) — emergency or outpatient:

  • Often performed in an emergency department or GP setting under local anaesthetic; lowest cost option.
  • US emergency department: USD $500–$2,000 (facility fee plus physician fee).
  • India: INR 1,000–5,000 (USD $12–$60) in most public or private hospitals.
  • UK NHS: Fully funded; no patient cost. Private clinics: £150–£400.

Word catheter insertion:

  • Similarly priced to I&D; the catheter itself costs approximately USD $20–$50 per unit.
  • US outpatient gynaecology: USD $500–$1,500 total including procedure and follow-up.
  • India (accredited gynaecology centre): INR 3,000–8,000 (USD $36–$96).
  • Australia (GP procedural): AUD $150–$400 with Medicare rebate; AUD $500–$1,000 privately.

Marsupialization (theatre procedure under GA or regional anaesthesia):

  • Requires anaesthesia and theatre booking — higher cost than office-based Word catheter.
  • US: USD $3,000–$6,000 (surgeon, anaesthesiologist, and facility fees).
  • India (NABH-accredited hospital): INR 15,000–40,000 (USD $180–$480).
  • UK NHS: Fully covered. Private: £1,200–£2,500.

Gland excision: The most expensive option due to general anaesthesia requirement, inpatient or daycase admission, and greater operative time.

  • US: USD $5,000–$10,000 total.
  • India: INR 25,000–70,000 (USD $300–$840).

Additional costs: STI testing (NAAT panels, culture, sensitivities): USD $50–$200. Antibiotic courses (if required): typically low cost with generic formulations. Histopathology (biopsy processing): USD $100–$400 in the US; generally included in NHS care in the UK.

Alternatives and Conservative Measures

Conservative and alternative approaches are appropriate in selected clinical situations but should not substitute for definitive procedural drainage in acute Bartholin's abscess:

  • Warm sitz baths and analgesics (expectant management): Appropriate only for very small (<2 cm), minimally symptomatic Bartholin's cysts in women who are not in acute pain. Warm sitz baths (10–15 minutes, 3–4 times daily) may encourage spontaneous drainage of small cysts. Not appropriate for confirmed abscess — warm soaking does not achieve adequate drainage of a walled-off pus collection and delays appropriate treatment.
  • Needle aspiration: Simple aspiration of the abscess cavity without catheter insertion or fistulisation. Rapid, painless under local anaesthetic, and easily performed. However, aspiration alone is associated with a very high recurrence rate (60–70%) within 6 months because no permanent neo-ostium is formed. Acceptable as a very short-term temporising measure if the patient cannot attend for definitive procedure promptly.
  • Jacobi ring catheter: An alternative to the Word catheter using a flexible plastic tube with two holes that is loop-sutured through two stab incisions to keep the tract open. Some practitioners prefer it for large abscesses as it allows more voluminous drainage. Success rates are comparable to Word catheter.
  • CO₂ laser marsupialization: Vaporisation of the cyst wall using a CO₂ laser rather than cold steel excision. Achieves haemostasis simultaneously with tissue removal; less bleeding in the highly vascular Bartholin's region. Available in specialist gynaecology laser centres; no superior efficacy data versus cold steel marsupialization, but may offer reduced intraoperative blood loss.
  • Botulinum toxin injection: Experimental data suggest intralesional botulinum toxin A injection may reduce recurrence by inducing gland atrophy. Published case series show promising results in recurrent cases; not yet standard of care and not widely available.
  • Sexual lubricant use post-excision: Women who have undergone gland excision and experience reduced vestibular lubrication during intercourse benefit from regular use of water-based or silicone-based lubricants during sexual activity. Vaginal moisturisers (e.g., Replens) used regularly can reduce chronic dryness symptoms.

Frequently Asked Questions

A Bartholin's cyst is a non-infected fluid collection (mucus) that forms when the Bartholin gland duct becomes obstructed. It is typically painless or only mildly uncomfortable, and may not require treatment if small and asymptomatic. A Bartholin's abscess is an acute bacterial infection of the gland or duct producing a hot, exquisitely tender, fluctuant swelling that develops rapidly over 24–48 hours and causes severe vulval pain and difficulty sitting or walking. An abscess always requires urgent procedural drainage — antibiotics alone are insufficient.
The Word catheter must remain inflated in the Bartholin's gland cavity for a minimum of 4–6 weeks. This duration allows the balloon to stimulate epithelialisation of a permanent fistulous tract (neo-ostium) from the gland to the vaginal surface. If the catheter is expelled or removed earlier, the tract closes and the abscess or cyst is likely to recur. At 4–6 weeks, the catheter is removed in the clinic by deflating the balloon with a needle and syringe — a simple, virtually painless procedure taking under a minute.
Penetrative vaginal intercourse should be avoided while the Word catheter is in situ for the full 4–6 week retention period. The catheter tail rests inside the vaginal opening and could be displaced by intercourse, disrupting the developing fistulous tract and risking recurrence. External sexual activity is generally acceptable if comfortable. After catheter removal at 4–6 weeks and confirmed wound healing, normal sexual activity can resume. The procedure does not affect sexual sensitivity or long-term function.
Bartholin's abscesses are caused by a range of bacteria. MRSA (methicillin-resistant Staphylococcus aureus) has become an increasingly important pathogen and, if present, requires specific targeted antibiotic therapy (e.g., doxycycline or trimethoprim-sulfamethoxazole based on sensitivities) rather than standard first-line antibiotics to which it is resistant. Neisseria gonorrhoeae and Chlamydia trachomatis can also cause Bartholin's infections in sexually active women; if untreated, these infections can ascend to cause pelvic inflammatory disease (PID). Swabbing at the time of presentation guides appropriate antibiotic selection and ensures sexual contacts are informed and tested where necessary.
Recurrence depends heavily on the initial treatment method. Simple incision and drainage alone has a recurrence rate of 15–20% within 12 months. Word catheter insertion reduces this to approximately 5–10% when retained for the full 4–6 weeks. Marsupialization offers the lowest recurrence rate in recurrent disease (5–10% long-term). If a woman has two or more recurrences, marsupialization is the recommended next step. Gland excision is reserved for three or more recurrences after failed marsupialization, or when Bartholin's gland carcinoma cannot be excluded (particularly in women over 40).

References

  1. Omole F, Simmons BJ, Hacker Y. Management of Bartholin's duct cyst and gland abscess. Am Fam Physician. 2003;68(1):135–40. PMID: 12887119
  2. Haider Z, Condous G, Kirk E, et al. Impact of the Word catheter in the treatment of Bartholin's abscesses and cysts. J Obstet Gynaecol. 2007;27(8):817–20. doi:10.1080/01443610701614521
  3. Wechter ME, Wu JM, Marzano D, Haefner H. Management of Bartholin duct cysts and abscesses: a systematic review. Obstet Gynecol Surv. 2009;64(6):395–404. doi:10.1097/OGX.0b013e31819f9298
  4. Lee MY, Dalpiaz A, Schwamb R, et al. Clinical pathology of Bartholin's glands: a review of the literature. Curr Urol. 2015;8(1):22–5. doi:10.1159/000365683
  5. RCOG/BASHH Joint Clinical Guidelines. Management of Bartholin's Cyst and Abscess. Royal College of Obstetricians and Gynaecologists. 2014 (reviewed 2020).
Ad — after-content

Medically Reviewed

Our medical content follows strict editorial guidelines to ensure accuracy and reliability.

Up to Date

Last updated: 2026-07-07

Important: This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis and treatment.

Ready to take the next step?

Connect with top hospitals and specialists. Get personalized guidance for your medical journey.

Latest from our blog and forum

Latest from Our Blog

View All →

Latest Forum Discussions

View All →
Compare Costs Get Free Help

Medical Disclaimer: The information on MyMedicPlus is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay seeking it because of something you have read on this site.